Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > Lucira looks promising
View:
Post by jsim082 on Jan 04, 2023 12:55pm

Lucira looks promising

This new partnership with Lucira looks like a very nice piece of work by DM.


Per Lucira's earnings call transcript for Q1 2022 they were receiving orders from Health Canada for the purpose of "providing value to remote and hard to reach communities". This sounds like a goal DM has also expressed.
(Source:
https://www.fool.com/earnings/call-transcripts/2022/05/13/lucira-health-inc-lhdx-q1-2022-earnings-call-trans/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article)

Also, Lucira does a significant amount of business, with 34 million in total revenue in the last quarter. Regardless of their negative EBITDA, that does suggest a fairly significant adoption of their product.

They are also working on other products, like Chlamydia and Gonorrhea testing.

If the eroding of our film industry test kit sales is inevitable, it could be nice to be in bed with a company like this.

Just my opinion.

JAGS

Comment by Markhamjohn on Jan 04, 2023 4:22pm
It seems that Lucira has also fallen victim to being perceived as mainly a Covid company. One year ago their stock price exceeded $8.00. Six months ago it was at Just over $3.00. today is it around $0.45. They can benefit from this new partnership just as DM can benefit. Their WEB site shows a home test kit now includes Telehealth ( from DM I assume) for a cost of $98.00 with a current sale ...more  
Comment by swyint123888 on Jan 04, 2023 4:48pm
Don't forget that the most common drug given for covid is plaxovid and in ontario you no longer need a Dr as a pharmacist can give it now.....I don't know what will happen with the actors union but we will find out in early Feb as the current agreement ends Jan 31....as far as managers thinking the actors can't do the test by themselves I mean come on keep ot real....dollars and cents ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse